Oxaprozin Enteric-coated Tablets
Function and Efficacy
It has anti-inflammatory, analgesic and antipyretic effects. It is an inhibitor of cyclooxygenase and thus inhibits the biosynthesis of prostaglandins. It has a mild effect on digestive tract damage and its efficacy is long-lasting.
Ingredients
The main ingredient of this product is: Oxaprozin. Its chemical name is: 4,5-diphenyloxazole-2-propionic acid. Molecular formula: C18H15NO3 Molecular weight: 293.32
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| OxaprozinIngredients |
It has anti-inflammatory, analgesic and antipyretic effects. It is an inhibitor of cyclooxygenase and thus inhibits the biosynthesis of prostaglandins. It has a mild effect on digestive tract damage and its efficacy is long-lasting. More |
21256-18-8 | 14 |
Appearance
White or off-white tablets, odorless or with a slight peculiar odor, slightly bitter taste.
Indication
It is suitable for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, periarthritis of shoulder, cervical shoulder and wrist syndrome, gout, and post-traumatic and post-operative analgesia.
Usage and Dosage
Oral administration, 0.2-0.4g (1-2 tablets) at a time, once a day, for more than 1 week or as directed by a doctor, after meals, the maximum dose is 0.6g (3 tablets) per day.
Precautions
Patients with peptic ulcer, severe liver and kidney diseases, patients allergic to other non-steroidal anti-inflammatory analgesics, patients with blood diseases, children, and pregnant and lactating women.
Special Population Medication
Precautions for children: Forbidden. Precautions for pregnancy and lactation: Forbidden. Precautions for the elderly: Elderly patients are prone to adverse reactions due to decreased liver and kidney function, so they should be used with caution or in a reduced dosage.
Drug Interactions
1. The combined use of this product with aspirin may increase the toxicity of aspirin because this product can replace salicylates bound to plasma proteins; 2. In the elderly and those with decreased renal function, it will reduce the clearance rate of digoxin, increase the blood concentration of the drug and increase its toxicity; 3. When used in large doses to treat tumors, it will affect the excretion of methotrexate, increase the blood concentration of methotrexate and cause poisoning; 4. It will affect the antihypertensive effect of antihypertensive drugs (angiotensin converting enzyme inhibitors and beta-receptor inhibitor blockers); 5. It will reduce the diuretic and sodium excretion effects of diuretics.
Storage
Keep away from light and store in sealed container.
Packaging Specification
0.2g
Validity Period
36 months.
Manufacturer
Wuhan Tongji Modern Pharmaceutical Technology Co., Ltd.
-
Founded in:
2000-12-26 -
Address:
No. 22, High-tech Industrial Park, Wuhan Economic and Technological Development Zone -
Tax NO.:
91420100725762555E -
Registered Funds:
156.855506 yuan -
Website:
-
Email: